HENSIFY Trademark

Trademark Overview


On Thursday, August 3, 2017, a trademark application was filed for HENSIFY with the United States Patent and Trademark Office. The USPTO has given the HENSIFY trademark a serial number of 79219471. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Tuesday, November 19, 2024. This trademark is owned by Nanobiotix. The HENSIFY trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical products, namely, agents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare products, namely, pharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapy, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking ...

Diagnostic apparatus for medical use, namely, X-ray apparatus for medical use; radiology screens for medical use
hensify

General Information


Serial Number79219471
Word MarkHENSIFY
Filing DateThursday, August 3, 2017
Status706 - SECTION 71 ACCEPTED
Status DateTuesday, November 19, 2024
Registration Number5435709
Registration DateTuesday, April 3, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 16, 2018

Trademark Statements


Description of MarkThe mark consists of the wording "HENSIFY" with a design of nine triangles forming a polygon to the upper right of the wording.
Goods and ServicesPharmaceutical products, namely, agents for tumor treatment for use only in relation to radiotherapy; medicines for human use for use only in relation to radiotherapy for cancer treatment; healthcare products, namely, pharmaceutical products for cancer treatment for use only in relation to radiotherapy; drugs for medical use for cancer treatment for use only in relation to radiotherapy; preparations for medical use for use only in relation to radiotherapy, particularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use for use only in relation to radiotherapy for cancer treatment; medical preparations for medical or pharmaceutical use consisting of medication delivery agents in the form of tablets and capsules for cancer treatment for use only in relation to radiotherapy; chemical-pharmaceutical products consisting in tablets or injectable products for cancer treatment for use only in relation to radiotherapy; diagnostic biomarking reagents for medical use for use only in relation to radiotherapy
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesDiagnostic apparatus for medical use, namely, X-ray apparatus for medical use; radiology screens for medical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, October 28, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, October 28, 2017
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNanobiotix
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressPARIS F-75012
FR

Party NameNanobiotix
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NameNanobiotix
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Friday, November 3, 2017ASSIGNED TO EXAMINER
Monday, November 6, 2017NON-FINAL ACTION WRITTEN
Tuesday, November 7, 2017NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, November 17, 2017REFUSAL PROCESSED BY MPU
Friday, November 17, 2017NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, December 2, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, December 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 5, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, December 9, 2017REFUSAL PROCESSED BY IB
Wednesday, December 27, 2017NOTICE OF PUBLICATION
Wednesday, January 10, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, January 10, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Saturday, January 27, 2018NOTIFICATION PROCESSED BY IB
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, July 3, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 10, 2018FINAL DISPOSITION PROCESSED
Tuesday, July 10, 2018FINAL DISPOSITION NOTICE SENT TO IB
Saturday, August 4, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, April 3, 2024TEAS SECTION 71 RECEIVED
Monday, November 18, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, November 19, 2024REGISTERED-SEC.71 ACCEPTED
Tuesday, November 19, 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Tuesday, January 16, 2018PUBLISHED FOR OPPOSITION
Thursday, October 26, 2017SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, October 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 1, 2017APPLICATION FILING RECEIPT MAILED